SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-045323
Filing Date
2019-08-12
Accepted
2019-08-12 17:01:44
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-10404_110q.htm 10-Q 820486
2 EX-10.7 a19-10404_1ex10d7.htm EX-10.7 17633
3 EX-31.1 a19-10404_1ex31d1.htm EX-31.1 11186
4 EX-31.2 a19-10404_1ex31d2.htm EX-31.2 11368
5 EX-32.1 a19-10404_1ex32d1.htm EX-32.1 5673
6 EX-32.2 a19-10404_1ex32d2.htm EX-32.2 5615
  Complete submission text file 0001104659-19-045323.txt   4845193

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cycn-20190630.xml EX-101.INS 1105865
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cycn-20190630.xsd EX-101.SCH 40138
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cycn-20190630_cal.xml EX-101.CAL 43853
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cycn-20190630_def.xml EX-101.DEF 120822
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cycn-20190630_lab.xml EX-101.LAB 400450
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cycn-20190630_pre.xml EX-101.PRE 275332
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 191017283
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences